IL103513A - History of Adenosine N - 2 - Dual-Transformed, Preparation and Pharmaceutical Preparations Containing Them - Google Patents
History of Adenosine N - 2 - Dual-Transformed, Preparation and Pharmaceutical Preparations Containing ThemInfo
- Publication number
- IL103513A IL103513A IL10351392A IL10351392A IL103513A IL 103513 A IL103513 A IL 103513A IL 10351392 A IL10351392 A IL 10351392A IL 10351392 A IL10351392 A IL 10351392A IL 103513 A IL103513 A IL 103513A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- formula
- set forth
- adenosine
- forth above
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK9100324 | 1991-10-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL103513A0 IL103513A0 (en) | 1993-03-15 |
IL103513A true IL103513A (en) | 1996-09-12 |
Family
ID=8153695
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10351392A IL103513A (en) | 1991-10-24 | 1992-10-22 | History of Adenosine N - 2 - Dual-Transformed, Preparation and Pharmaceutical Preparations Containing Them |
Country Status (11)
Country | Link |
---|---|
US (2) | US5432164A (fr) |
EP (1) | EP0609375A1 (fr) |
JP (1) | JPH07500586A (fr) |
AU (1) | AU657374B2 (fr) |
CA (1) | CA2121844A1 (fr) |
FI (1) | FI941876A (fr) |
IL (1) | IL103513A (fr) |
NO (1) | NO300461B1 (fr) |
NZ (1) | NZ244875A (fr) |
WO (1) | WO1993008206A1 (fr) |
ZA (1) | ZA928222B (fr) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5432164A (en) * | 1991-10-24 | 1995-07-11 | Novo Nordisk A/S | C2,N6 -disubstituted adenosine derivatives |
US5589467A (en) * | 1993-09-17 | 1996-12-31 | Novo Nordisk A/S | 2,5',N6-trisubstituted adenosine derivatives |
EP0704215A3 (fr) * | 1994-06-02 | 1998-04-01 | Takeda Chemical Industries, Ltd. | Inhibiteur de l'aumentation de la perméabilité vasculaire |
AU2022597A (en) * | 1996-03-13 | 1997-10-01 | Novo Nordisk A/S | A method of treating disorders related to cytokines in mammals |
WO1997033590A1 (fr) * | 1996-03-13 | 1997-09-18 | Novo Nordisk A/S | Procede de traitement d'affections associees aux cytokines chez les mammiferes |
US5789416B1 (en) * | 1996-08-27 | 1999-10-05 | Cv Therapeutics Inc | N6 mono heterocyclic substituted adenosine derivatives |
AU4377397A (en) * | 1996-10-14 | 1998-05-11 | Novo Nordisk A/S | Novel therapeutically active adenosine derivatives |
US6110902A (en) * | 1997-06-23 | 2000-08-29 | Moehler; Hanns | Method for the inhibition of neuronal activity leading to a focal epileptic seizure by local delivery of adenosine |
US6175004B1 (en) * | 1998-09-01 | 2001-01-16 | Isis Pharmaceuticals, Inc. | Process for the synthesis of oligonucleotides incorporating 2-aminoadenosine |
US6576619B2 (en) | 1999-05-24 | 2003-06-10 | Cv Therapeutics, Inc. | Orally active A1 adenosine receptor agonists |
US6294522B1 (en) * | 1999-12-03 | 2001-09-25 | Cv Therapeutics, Inc. | N6 heterocyclic 8-modified adenosine derivatives |
US7342003B2 (en) * | 2001-10-25 | 2008-03-11 | King Pharmaceuticals Research And Development, Inc. | Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs |
KR20050097971A (ko) * | 2003-02-03 | 2005-10-10 | 씨브이 쎄러퓨틱스, 인코포레이티드 | A₁아데노신 수용체의 부분 및 전 작용제 |
WO2005033121A2 (fr) * | 2003-10-03 | 2005-04-14 | King Pharmaceuticals Research & Development, Inc. | Synthese de 2-aralkyloxyadenosines, 2-alkoxyadenosines, et leurs analogues |
EP2021350B1 (fr) | 2006-03-21 | 2016-12-21 | Rheinische Friedrich-Wilhelms-Universität Bonn | Agonistes du récepteur a2a phosphorylé |
WO2015094759A1 (fr) | 2013-12-19 | 2015-06-25 | The Procter & Gamble Company | Façonnage de fibres de kératine utilisant un principe actif comprenant au moins deux groupes fonctionnels choisis entre -c(oh)- et -c(=o)oh |
CN107106438A (zh) | 2014-12-19 | 2017-08-29 | 宝洁公司 | 成形角蛋白纤维的方法 |
EP3297731A1 (fr) | 2014-12-19 | 2018-03-28 | The Procter and Gamble Company | Modelage de fibres de kératine à l'aide d'arabinose et de carbonate d'éthylène |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE768925A (fr) * | 1970-06-30 | 1971-11-03 | Takeda Chemical Industries Ltd | Derives d'adenosine et procede de preparation |
JPH0696534B2 (ja) * | 1986-04-25 | 1994-11-30 | ヘキストジヤパン株式会社 | 抗痴呆剤 |
US5017578A (en) * | 1989-06-09 | 1991-05-21 | Hoechst-Roussel Pharmaceuticals Inc. | N-heteroaryl-purin-6-amines useful as analgesic and anticonvulsant agents |
CA2028002A1 (fr) * | 1989-10-19 | 1991-04-20 | Daniel P. Becker | Methode de traitement des troubles de la motilite gastro-intestinale |
US5432164A (en) * | 1991-10-24 | 1995-07-11 | Novo Nordisk A/S | C2,N6 -disubstituted adenosine derivatives |
-
1992
- 1992-10-20 US US07/963,878 patent/US5432164A/en not_active Expired - Fee Related
- 1992-10-21 EP EP92923113A patent/EP0609375A1/fr not_active Ceased
- 1992-10-21 AU AU29160/92A patent/AU657374B2/en not_active Ceased
- 1992-10-21 JP JP5507362A patent/JPH07500586A/ja active Pending
- 1992-10-21 WO PCT/DK1992/000307 patent/WO1993008206A1/fr not_active Application Discontinuation
- 1992-10-21 CA CA002121844A patent/CA2121844A1/fr not_active Abandoned
- 1992-10-22 IL IL10351392A patent/IL103513A/en not_active IP Right Cessation
- 1992-10-23 ZA ZA928222A patent/ZA928222B/xx unknown
- 1992-10-23 NZ NZ244875A patent/NZ244875A/en unknown
-
1994
- 1994-04-22 FI FI941876A patent/FI941876A/fi not_active Application Discontinuation
- 1994-04-22 NO NO941477A patent/NO300461B1/no unknown
-
1995
- 1995-05-05 US US08/435,005 patent/US5578582A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
NO300461B1 (no) | 1997-06-02 |
CA2121844A1 (fr) | 1993-04-29 |
IL103513A0 (en) | 1993-03-15 |
JPH07500586A (ja) | 1995-01-19 |
FI941876A (fi) | 1994-06-22 |
FI941876A0 (fi) | 1994-04-22 |
WO1993008206A1 (fr) | 1993-04-29 |
AU2916092A (en) | 1993-05-21 |
AU657374B2 (en) | 1995-03-09 |
NO941477L (fr) | 1994-06-23 |
NO941477D0 (no) | 1994-04-22 |
US5578582A (en) | 1996-11-26 |
EP0609375A1 (fr) | 1994-08-10 |
US5432164A (en) | 1995-07-11 |
NZ244875A (en) | 1995-04-27 |
ZA928222B (en) | 1994-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5589467A (en) | 2,5',N6-trisubstituted adenosine derivatives | |
US5578582A (en) | Methods of treating ischemia with C2, N6 -disubstituted adenosine derivatives | |
EP1292604B1 (fr) | Derives de 2-aminocarbonyl-9h-purine | |
US20060122145A1 (en) | 2-Aminocarbonyl-9H-purine derivatives | |
US5430027A (en) | 2-chloro-N6 -substituted adenosines, their pharmaceutical compositions, and activity in treating ischemias | |
US5484774A (en) | 2, N6 -disubstituted adenosines, tri-O-ester derivatives and their pharmaceutical compositions to treat ischemias | |
AU4061293A (en) | Purine derivatives | |
US5683989A (en) | Treatment of ischemias by administration of 2,N6 -substituted adenosines | |
WO1998016539A1 (fr) | Nouveaux derives d'adenosine a action therapeutique | |
WO1997033590A1 (fr) | Procede de traitement d'affections associees aux cytokines chez les mammiferes | |
Knutsen et al. | C2, N 6-disubstituted adenosine derivatives | |
US5672588A (en) | Purine derivatives | |
UA73579C2 (en) | 2-aminocarbonyl-9n-purine derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
RH | Patent void |